Results 121 to 130 of about 1,327 (186)

An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target. [PDF]

Front Pharmacol
Gunther K, Liu D, Stannard G, Holmes M, Loo C, Guo B, Bowden N, Abbott J, Ford CE.   +8 more
europepmc   +1 more source

Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study. [PDF]

J Headache Pain
Wang J, Jiang J, Peng S, Jiang J, Liu Z, Cai J, Li J, Li Y, Chen Y, Li H, Rong X, He L, Ren L, Ji Y, Li S, Zhu Y, Xiao S, Tang Y, Xu Y.   +18 more
europepmc   +1 more source

The influence of renal impairment on the pharmacokinetics of rimegepant: Results of a phase 1, open-label, single-dose, parallel-group study. [PDF]

Headache
Bhardwaj R, Morris B, Bertz R, Matschke K, Croop R, Liu J.   +5 more
europepmc   +1 more source

Oral rimegepant as a preventive treatment of migraine: a plain language summary of a clinical study. [PDF]

Pain Manag
Croop R, Lipton RB, Kudrow D, Kamen L, Conway CM, Goadsby PJ.   +5 more
europepmc   +1 more source

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial. [PDF]

Headache
Ikeda K, Matsumori Y, Kudo M, Ishikawa T, Hoshino Y, Yoshimatsu H, Thiry A, Arakawa A, Croop R, Fullerton T, Sakai F, Takeshima T.   +11 more
europepmc   +1 more source

Innovative treatments for migraine: a new era. [PDF]

Ther Adv Neurol Disord
Pistoia F.
europepmc   +1 more source

Current and emerging evidence-based treatment options in chronic migraine: A narrative review [PDF]

, 2019
Agostoni, E. C., Barbanti, Paolo, Calabresi, P., Colombo, B., Cortelli, P., Frediani, Federico, Geppetti, P., Grazzi, L., Leone, Manfredi, Martelletti, P., Pini, L. A., Prudenzano, M. P., Russo, A., Sarchielli, P., Tedeschi, G.   +14 more
core   +1 more source

Circulating CGRP as a diagnostic biomarker in female migraine patients: a single-center case-control study. [PDF]

J Headache Pain
Huang Q, Li N, Dou H, Han H, Suo M, Wang Y, Jin J, Wang X, Zhou X, Rong R, Fan Z, Guan Q, Xu Y, Zhang Q.   +13 more
europepmc   +1 more source

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial. [PDF]

Headache
Kitamura S, Matsumori Y, Yamamoto T, Ishikawa T, Hoshino Y, Yoshimatsu H, Thiry A, Arakawa A, Croop R, Fullerton T, Sakai F, Takeshima T.   +11 more
europepmc   +1 more source

Rimegepant orally disintegrating tablet for acute treatment of migraine: a plain language summary of a clinical study. [PDF]

Pain Manag
Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Lipton RB.   +6 more
europepmc   +1 more source